When will Pennsylvania, one of the states affected most by Lyme, stop doing so little about it?
“I think [SB 1199] has a chance now because of the hearing,” Greenleaf told me over the phone just over a week after the hearings. “There was a very compelling accounts by people afflicted by this disease.”
But meanwhile, White no longer sounds like an infuriated storm-trooper for sick citizens. He sounds more like, well, a politican.
“At this point, there are many concerns with SB1199 as written,” White recently commented in an email. “There is no proven course of treatment, an uncertain liability factor for providers, and the mandate on insurers to pay for certain treatments could ultimately increase insurance premiums for consumers.”
When will Pennsylvania, one of the states affected most by Lyme, stop doing so little about it? Maybe next hearing, all 80,000 people in Pennsylvania with Lyme Disease should show up. You know, if they have the energy leftover from untreated Lyme or money from out-of-pocket treatments to get there.
Letters to the Editor